Simon Evans
Director of Finance/CFO at National Pharma Services
Profile
Simon Evans is a former Executive Director & Group Finance Director at Dechra Pharmaceuticals Plc where he worked from 1997 to 2012.
Prior to that, he was the Group Finance Director at National Pharma Services from 1992 to present (current job).
Simon Evans active positions
Companies | Position | Start |
---|---|---|
National Pharma Services
National Pharma Services Pharmaceuticals: MajorHealth Technology National Pharma Services provides pharmaceutical services. Martin Riley has been the CEO of the British company since 2005. | Director of Finance/CFO | 03/09/2010 |
Former positions of Simon Evans
Companies | Position | End |
---|---|---|
DECHRA PHARMACEUTICALS | Director of Finance/CFO | 19/10/2012 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Dechra Pharmaceuticals Plc
Dechra Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Dechra Pharmaceuticals Ltd. is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom. | Health Technology |
National Pharma Services
National Pharma Services Pharmaceuticals: MajorHealth Technology National Pharma Services provides pharmaceutical services. Martin Riley has been the CEO of the British company since 2005. | Health Technology |
- Stock Market
- Insiders
- Simon Evans